Related Experiment Video
Updated: May 15, 2026
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiation
Efrat Landau1, Frederick A Boop, Heather M Conklin
1Department of Radiation Oncology, Sheba Medical Center, Ramat Gan, Israel.
Insights
Radiation therapy for pediatric supratentorial ependymoma shows good disease control and acceptable complication risks. Focal irradiation methods may further limit adverse effects in children.
Area of Science:
- Pediatric neuro-oncology
- Radiation oncology
- Clinical outcomes research
Background:
- Supratentorial ependymoma is a rare brain tumor with distinct characteristics.
- Understanding treatment outcomes and complications is crucial for improving pediatric care.
Purpose of the Study:
- To evaluate disease control and complications of radiation therapy (RT) in children with supratentorial ependymoma.
- To assess the impact of conformal RT on neurological, endocrine, and cognitive functions.
Main Methods:
- Retrospective analysis of 50 children with newly diagnosed supratentorial ependymoma treated with adjuvant RT.
- Prospective evaluation of neurological, endocrine, and cognitive effects in 36 children treated with conformal RT after 1996.
Main Results:
- 10-year progression-free survival was 73% and overall survival was 76%.
- Clinically significant cognitive effects were mainly associated with difficult-to-control seizures; overall academic achievement remained within normal limits.
- Central hypothyroidism was the most frequent endocrinopathy.
Conclusions:
- Radiation therapy can be administered with acceptable risks for children with supratentorial ependymoma.
- Outcomes are improving, and focal irradiation may minimize complications.
Purpose:
Ependymoma is less commonly found in the supratentorial brain and has known clinical and molecular features that are unique. Our single-institution series provides valuable information about disease control for supratentorial ependymoma and the complications of supratentorial irradiation in children.
Methods And Materials:
A total of 50 children with newly diagnosed supratentorial ependymoma were treated with adjuvant radiation therapy (RT); conformal methods were used in 36 after 1996. The median age at RT was 6.5 years (range, 1-18.9 years). The entire group was characterized according to sex (girls 27), race (white 43), extent of resection (gross-total 46), and tumor grade (anaplastic 28). The conformal RT group was prospectively evaluated for neurologic, endocrine, and cognitive effects.
Results:
With a median follow-up time of 9.1 years from the start of RT for survivors (range, 0.2-23.2 years), the 10-year progression-free and overall survival were 73% + 7% and 76% + 6%, respectively. None of the evaluated factors was prognostic for disease control. Local and distant failures were evenly divided among the 16 patients who experienced progression. Eleven patients died of disease, and 1 of central nervous system necrosis. Seizure disorders were present in 17 patients, and 4 were considered to be clinically disabled. Clinically significant cognitive effects were limited to children with difficult-to-control seizures. The average values for intelligence quotient and academic achievement (reading, spelling, and math) were within the range of normal through 10 years of follow-up. Central hypothyroidism was the most commonly treated endocrinopathy.
Conclusion:
RT may be administered with acceptable risks for complications in children with supratentorial ependymoma. These results suggest that outcomes for these children are improving and that complications may be limited by use of focal irradiation methods.
